A new era in surgery is coming
We are bringing over a century of experience working alongside surgeons to usher in the next era in surgery.
The future of robotic surgery will be more human, more adaptive and more connected.
We are developing a robotic surgical platform that will set a new standard for the modern OR and transform the surgical experience.
Designing in partnership
We're working together with surgeons, clinical teams, and hospitals to find ways to better serve patients through the promise of robotic surgery.
Focusing on the biggest challenges of today
of surgeons cite scheduling and access to the robot as a top barrier to performing more cases robotically.1
By designing robotic surgery systems to better integrate into existing hospital systems and surgical workflows, technology can help enable greater access.
As surgeons and surgical teams face the physical and mental pressures of surgery, new technologies can enable teams to work more comfortably, engage more seamlessly and move through the OR more easily.
of general surgeons suffer from symptoms of burnout.2
of the world’s data is health data.3
Connecting health data inside the OR and out can surface insights for surgical teams to support decision making when it matters most.
OTTAVA™
Johnson & Johnson MedTech Announces Completion of First Cases with OTTAVA™ Robotic Surgical System
First use in gastric bypass at Memorial Hermann-Texas Medical Center
Trial will support submission for multiple procedures
Dr. Erik Wilson*, Chief of Minimally Invasive and Elective General Surgery UT Health Houston and the lead investigator for the clinical study, performed Roux-en-Y gastric bypass surgery using the OTTAVA Robotic Surgical System at Memorial Hermann-Texas Medical Center.
“Surgical robotics is at the forefront of innovation in minimally invasive surgery,” Dr. Wilson said. “I am proud to have performed the first clinical study cases with OTTAVA and potentially help advance the standard in surgical robotics.”
OTTAVA is designed as a multi-specialty soft-tissue surgery robot, supporting a broad range of procedures across patient anatomy and surgical specialties, including the most complex surgeries that require a multi-quadrant approach.
Data from this investigation aims to support the system's ability to perform a variety of procedures. Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States, targeting an indication covering multiple procedures in general surgery within the upper abdomen, such as gastric bypass, gastric sleeve, small bowel resection and hiatal hernia repair.
“We are proud to reach this important milestone in our robotic surgery program,” said Hani Abouhalka, Company Group Chairman, Surgery, Johnson & Johnson MedTech. “OTTAVA is a key innovation in our portfolio of advanced surgical technologies – all of which are designed to transform the surgical experiences across all surgery. Our people work side-by-side with surgical teams in ORs around the world every day to raise the standard of care for patients and deliver what’s next in surgery.”
“We believe the future of surgery is personal. Starting with the human impact – the connection between the patient, surgeon, and OR staff – we are unlocking what science and technology can do to improve the surgical experience and health outcomes for everyone involved. OTTAVA is designed to consistently deliver this experience in any OR globally.”
Hani AbouhalkaCompany
Group Chairman, Robotics & Digital
“The industry needs a system that is adaptable, easy to use in any OR in the world, and maintains space in the OR. As surgeons, we need space to improve the workflow in the OR, increase safety, and enable 360-degree patient access so we can perform at the capacity that we would like to. That’s where OTTAVA comes in. OTTAVA offers a unique design that incorporates into any OR and allows surgeons to do what they would like to do and know how to do, which is focus on the patient.”
Dr. Eduardo Parra-Davila
Colorectal and General Surgeon, Palm Beach Digital Surgery Institute
The OTTAVA™ Robotic System is under development and is not authorized to be marketed or sold in any market.
*Dr. Wilson is a paid consultant for Johnson & Johnson MedTech
1 Based on a September 2023 internally conducted survey of 146 surgeons worldwide with experience in robotic surgery.
1 Based on a September 2023 internally conducted survey of 146 surgeons worldwide with experience in robotic surgery.
2 Golisch, K. B., Sanders, J. M., Rzhetsky, A., & Tatebe, L. C. (2023). Addressing surgeon burnout through a multi-level approach: A National Call to Action. Current Trauma Reports, 9(2), 28–39.
3 The Healthcare Data Explosion Website. https://www.rbccm.com/en/gib/healthcare/episode/the_healthcare_data_explosion. Accessed October 24, 2023.
© Ethicon US, LLC. 2023. All rights reserved. US_ETH_RADS_300118